These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38520603)

  • 1. Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes.
    Gupta A; Goyal A; Rajan R; Vishnu VY; Kalaivani M; Tandon N; Srivastava MVP; Gupta Y
    Diabetes Ther; 2024 May; 15(5):1155-1168. PubMed ID: 38520603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Slovenian version of the Montreal Cognitive Assessment Scale as a screening tool for the detection of mild cognitive impairment.
    Špeh A; Kalar I; Pirtošek Z; Kramberger MG
    Acta Neurol Belg; 2024 Apr; 124(2):543-547. PubMed ID: 38436822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the German Montreal-Cognitive-Assessment-H for hearing-impaired.
    Völter C; Fricke H; Faour S; Lueg G; Nasreddine ZS; Götze L; Dawes P
    Front Aging Neurosci; 2023; 15():1209385. PubMed ID: 37539344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of different operational definitions on mild cognitive impairment rate and MMSE and MoCA performance in transient ischaemic attack and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Cerebrovasc Dis; 2013; 36(5-6):355-62. PubMed ID: 24217342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.
    O'Caoimh R; Timmons S; Molloy DW
    J Alzheimers Dis; 2016; 51(2):619-29. PubMed ID: 26890758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Montreal cognitive assessment against the RBANS in a healthy South African cohort.
    Beath N; Asmal L; van den Heuvel L; Seedat S
    S Afr J Psychiatr; 2018; 24():1304. PubMed ID: 30349744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.
    Yu J; Li J; Huang X
    BMC Psychiatry; 2012 Sep; 12():156. PubMed ID: 23009126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometrics and diagnostic properties of the Montreal Cognitive Assessment 5-min protocol in screening for Mild Cognitive Impairment and dementia among older adults in Tanzania: A validation study.
    Masika GM; Yu DSF; Li PWC; Wong A; Lin RSY
    Int J Older People Nurs; 2021 Jan; 16(1):e12348. PubMed ID: 32920984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Properties of the Persian Montreal Cognitive Assessment in Mild Cognitive Impairment and Alzheimer Disease.
    Rashedi V; Foroughan M; Chehrehnegar N
    Dement Geriatr Cogn Dis Extra; 2021; 11(1):51-57. PubMed ID: 33976692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment.
    Thomann AE; Berres M; Goettel N; Steiner LA; Monsch AU
    Alzheimers Res Ther; 2020 Apr; 12(1):39. PubMed ID: 32264975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
    Hoops S; Nazem S; Siderowf AD; Duda JE; Xie SX; Stern MB; Weintraub D
    Neurology; 2009 Nov; 73(21):1738-45. PubMed ID: 19933974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?
    Larner AJ
    Int Psychogeriatr; 2012 Mar; 24(3):391-6. PubMed ID: 22014176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Mild Cognitive Impairment Among Community-Dwelling African Americans Using the Montreal Cognitive Assessment.
    Rossetti HC; Smith EE; Hynan LS; Lacritz LH; Cullum CM; Van Wright A; Weiner MF
    Arch Clin Neuropsychol; 2019 Aug; 34(6):809-813. PubMed ID: 30517598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the MoCA as a cognitive screening tool in epilepsy: Are there implications for global care and research?
    Reyes A; Hermann BP; Prabhakaran D; Ferguson L; Almane DN; Shih JJ; Iragui-Madoz VJ; Struck A; Punia V; Jones JE; Busch RM; McDonald CR
    Epilepsia Open; 2024 Aug; 9(4):1526-1537. PubMed ID: 38874380
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.